3M Co (MMM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:3M Co (MMM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7454
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanotechnology, and surface modification, among others. The company offers its products to diverse sectors ranging from healthcare to automotive to electronics, health care, safety and graphics, and energy to industrial and consumer. 3M markets its products through wholesalers, retailers, jobbers, distributors, dealers, sales representatives and direct to users. The company has operations in North and South America; Europe, the Middle East and Africa; and Asia-Pacific. 3M is headquartered in St. Paul, Minnesota, the US.

3M Co (MMM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
3M Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3M Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
3M Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3M Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
3M Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
3M Co, Medical Equipment, Deal Details 12
Asset Purchase 12
3M Acquires Separations Media Business from Polypore for USD1 Billion 12
Partnerships 14
Dental Direkt Enters into Licensing Agreement with 3M 14
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 15
Bruker Extends Licensing Agreement With 3M Company 16
3M Enters into Licensing Agreement with University of Colorado Boulder for Dental Polymer Technology 17
3M Company Enters Into Licensing Agreement With Wieland Dental + Technik For Zirconia Technology 18
3M Health Information Systems Enters Into Licensing Agreement With Healthland 19
M*Modal Enters Into Licensing Agreement With 3M Health Information Systems 20
3M Enters Into Licensing Agreement With Zirkonzahn For Dental Ceramic Coloring Technology 21
3M Health Information Systems Enters into Agreement with Verily Life Science 22
M*Modal Enters Into Technology Integration Agreement With 3M Health Information Systems 23
Equity Offering 24
3M India Announces Public Offering Of Shares For US$6 Million 24
Debt Offering 25
3M Company Raises USD500 Million in Public Offering of Series F 3.625% Notes Due 2047 25
3M Company Raises USD650 Million in Public Offering of Series F 2.25% Notes Due 2023 26
3M Company Raises USD850 Million in Public Offering of Series F 2.875% Notes Due 2027 27
3M Company Raises USD600 Million in Public Offering of Series F Fixed Rate Notes Due 2021 28
3M Company Completes Public Offering Of 1.875% Bonds Due 2021 For US$809 Million 29
Acquisition 30
3M Acquires Ivera Medical 30
Avista Capital Partners and Nordic Capital May Sell ConvaTec 31
3M Completes Acquisition Of Treo Solutions, Healthcare IT Company 32
3M Company Acquires 100% Stake in Ceradyne 33
3M Completes Acquisition Of Ceradyne, Maker Of Ceramic Products, For US$860 Million 35
3M Health Acquires CodeRyte, Provider Of Healthcare And Computer Technology 37
3M Co – Key Competitors 39
3M Co – Key Employees 40
3M Co – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 45
Financial Announcements 45
Jan 25, 2018: 3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook 45
Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook 48
Corporate Communications 50
May 21, 2018: 3M forms sustainability and product stewardship organization 50
May 09, 2018: 3M Announces New Leadership Appointment 51
Mar 05, 2018: 3M Announces New Leadership Appointments 52
Nov 15, 2017: 3M Announces Management Changes 53
Oct 02, 2017: 3M Announces New Leadership Appointments 54
Aug 14, 2017: Amy E. Hood Elected to 3M Board of Directors 55
Jun 20, 2017: 3M Announces New Leadership Appointments 56
Product News 57
Jan 03, 2018: Medical Design Engineers’ Adhesive Selection Process Made Easier With New 3M Product Selector Tool 57
Jun 22, 2017: Largest Body of Evidence on Clinical Benefits of Patient Warming Now Available 58
Apr 19, 2017: Patent-Protected Indirect Bonding Techniques from 3M Oral Care 59
Other Significant Developments 60
May 18, 2017: U.S. Army and 3M Provide Hearing Protection for Soldiers 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
3M Co, Medical Equipment, Key Facts, 2017 2
3M Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
3M Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3M Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
3M Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3M Co, Deals By Market, 2012 to YTD 2018 9
3M Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
3M Acquires Separations Media Business from Polypore for USD1 Billion 12
Dental Direkt Enters into Licensing Agreement with 3M 14
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 15
Bruker Extends Licensing Agreement With 3M Company 16
3M Enters into Licensing Agreement with University of Colorado Boulder for Dental Polymer Technology 17
3M Company Enters Into Licensing Agreement With Wieland Dental + Technik For Zirconia Technology 18
3M Health Information Systems Enters Into Licensing Agreement With Healthland 19
M*Modal Enters Into Licensing Agreement With 3M Health Information Systems 20
3M Enters Into Licensing Agreement With Zirkonzahn For Dental Ceramic Coloring Technology 21
3M Health Information Systems Enters into Agreement with Verily Life Science 22
M*Modal Enters Into Technology Integration Agreement With 3M Health Information Systems 23
3M India Announces Public Offering Of Shares For US$6 Million 24
3M Company Raises USD500 Million in Public Offering of Series F 3.625% Notes Due 2047 25
3M Company Raises USD650 Million in Public Offering of Series F 2.25% Notes Due 2023 26
3M Company Raises USD850 Million in Public Offering of Series F 2.875% Notes Due 2027 27
3M Company Raises USD600 Million in Public Offering of Series F Fixed Rate Notes Due 2021 28
3M Company Completes Public Offering Of 1.875% Bonds Due 2021 For US$809 Million 29
3M Acquires Ivera Medical 30
Avista Capital Partners and Nordic Capital May Sell ConvaTec 31
3M Completes Acquisition Of Treo Solutions, Healthcare IT Company 32
3M Company Acquires 100% Stake in Ceradyne 33
3M Completes Acquisition Of Ceradyne, Maker Of Ceramic Products, For US$860 Million 35
3M Health Acquires CodeRyte, Provider Of Healthcare And Computer Technology 37
3M Co, Key Competitors 39
3M Co, Key Employees 40
3M Co, Subsidiaries 42

List of Figures
3M Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
3M Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
3M Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
3M Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
3M Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
3M Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
3M Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
3M Co, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[3M Co (MMM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Scripps Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Nitori Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nuverra Environmental Solutions, Inc. (NES)-石油・ガス分野:企業M&A・提携分析
    Summary Nuverra Environmental Solutions, Inc. (Nuverra), formerly known as Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, coll …
  • Poyry PLC:企業のM&A・事業提携・投資動向
    Poyry PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Poyry PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Betco Corp:企業の戦略的SWOT分析
    Betco Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Maruishi Pharmaceutical Co Ltd (Maruishi) is a pharmaceutical company that develops and sells medical drugs. The company offers products in the fields of perioperative and infection control. Its products include anesthetics, perioperative drugs, pharmacopoeia drugs, and disinfectants and ant …
  • TriMedx LLC:企業の戦略的SWOT分析
    TriMedx LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • Mitralign Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company’s products include crossing wire, pledget delivery catheter and placation lock delivery catheter, …
  • Fluidigm Corp (FLDM):企業の財務・戦略的SWOT分析
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • BlackBerry Ltd:企業のM&A・事業提携・投資動向
    BlackBerry Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackBerry Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Eregli Demir ve Celik Fabrikalari TAS:企業の戦略・SWOT・財務情報
    Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report Summary Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sanochemia Pharmazeutika AG (SAC):企業の財務・戦略的SWOT分析
    Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Telefonica UK Limited:企業の戦略的SWOT分析
    Telefonica UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆